Roth James H

Director Roth James H sold 8,641 shares of HURN for $1,230,328.82 across 5 separate transactions on 2025-03-26 at prices ranging from $141.30 to $145.62.

James H Roth, a director at Huron Consulting, executed 5 separate sales totaling 8,641 shares for $1,230,328.82 on March 26, 2025, reducing his holdings by 15.4% to 47,638 shares post-transaction. The sales occurred at prices between $141.30 and $145.62, with a blended average of $142.38, while the current market price stands at $142.30, indicating the transactions executed near present market levels. Roth's cross-ticker historical track record shows 10 prior sells, but his same-ticker history at HURN reveals only recent activity (five prior trades in early-to-mid March, all sells, with outcomes not yet measurable at 90 days). Without additional context on whether this filing represents scheduled trading under a Rule 10b5-1 plan or discretionary open-market activity, this sale represents a material reduction in an individual director's exposure but lacks sufficient historical timing pattern evidence at this ticker to signal broader conviction shifts.

HURN director Roth sells 8,642 shares across 3 trades totaling $1,289,989.38; retains 56,279 shares post-sale

Director James H. Roth executed 3 separate open-market sales on 2025-03-19, totaling 8,642 shares for $1,289,989.38 at a blended average price of $149.27, reducing his holdings by 13.3% to 56,279 shares. The transaction occurred 7 days after a cluster of 4 sales on 2025-03-12 and represents a continuation of recent selling activity at the ticker. At the current price of $140.87, the stock has retreated 7.6% from its 52-week high of $152.46, though it has appreciated 7.4% over the prior 30 days and 15.5% over 90 days. With HURN trading at a P/E of 17.83 and posting annual revenue growth of 8.8% on a $378.1M quarterly revenue base, the company maintains solid operational fundamentals; the disposal itself does not signal deterioration in the underlying business.

Director Roth James H sold 8,642 shares at $142.43–$145.34 on 2025-03-12 for $1,243,802.01

Director James H Roth executed four separate sales totaling 8,642 shares for $1,243,802.01 at prices ranging from $142.43 to $145.34 on 2025-03-12, reducing his holdings by -11.7% to 64,921 shares. The sales occurred as HURN traded near its 52-week high of $152.46 (current price of $147.76 is -3.1% below peak), and followed immediately after three prior sells by the same insider on 2025-03-05, suggesting a concentrated divestment pattern over consecutive trading days. With cross-ticker open-market history of only 3 prior sales and SAME-TICKER history showing his three prior trades on 2025-03-05 with outcomes not yet measurable, this filing provides limited predictive signal from his historical timing accuracy. The company's fundamentals remain solid (P/E of 18.70, annual revenue growth of +8.8%, net income of $27,149,000.00), and HURN's stock is up 22.5% over 90 days, offering no obvious fundamental distress signal corresponding to the divestment.

Director Roth sells 8,642 shares of HURN for $1,278,364.16 at $147.92 average (near 52-week high)

On 2025-03-05, James H Roth, a Director at Huron Consulting Group Inc., executed 3 separate sales totaling 8,642 shares for $1,278,364.16. The blended average sale price of $147.92 places the transactions at the upper end of the 52-week range ($85.22–$152.46), approximately -2.1% from the 52-week high. Post-transaction holdings of 73,563 shares represent a -10.5% reduction from the prior 82,205 shares. The stock has appreciated +18.3% over the prior 30 days and +21.3% over 90 days, and HURN's fundamentals show stable growth with +8.8% annual revenue growth and a reasonable P/E of 18.90. The sale's proximity to recent price highs and elevated momentum warrants examination of the filer's prior trade patterns and any company-specific context.